ResMed Announces Participation in the UBS Global Healthcare Conference
05 Novembre 2024 - 10:05PM
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman
and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical
Officer, will participate in a fireside chat at the UBS Global
Healthcare Conference on Tuesday, November 12, 2024, beginning at
approximately 3:30 p.m. (Pacific Standard Time) at the Terranea
Resort Hotel in Rancho Palos Verdes, CA.
More information about this event, including access
to the live, audio-only webcast, may be accessed by visiting
https://investor.resmed.com. The audio-only webcast replay will be
available approximately 24 hours after the live webcast ends and
will be accessible for the following thirty (30) days.
About ResMedAt ResMed (NYSE: RMD,
ASX: RMD) we pioneer innovative solutions that treat and keep
people out of the hospital, empowering them to live healthier,
higher-quality lives. Our digital health technologies and
cloud-connected medical devices transform care for people with
sleep apnea, COPD, and other chronic diseases. Our comprehensive
out-of-hospital software platforms support the professionals and
caregivers who help people stay healthy in the home or care setting
of their choice. By enabling better care, we improve quality of
life, reduce the impact of chronic disease, and lower costs for
consumers and healthcare systems in more than 140
countries. To learn more, visit ResMed.com and follow
@ResMed.
For
investors |
|
For
media |
+1 858.836.5000 |
|
+1 619.510.1281 |
investorrelations@resmed.com |
|
news@resmed.com |
ResMed (NYSE:RMD)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
ResMed (NYSE:RMD)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024